Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism PGI2 receptor agonists(Prostanoid IP receptor agonists) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC30H27NNaO4 |
InChIKeyRNVBYINHJQEUAG-JIDHJSLPSA-N |
CAS Registry171046-15-4 |